Thumb Arthritis Market Size, Share, Demand, Financial Overview, Key Developments, Swot Analysis and Forecast to 2027


Posted June 21, 2021 by deppgaikwad

Market Research Future Adds The “Thumb Arthritis Market Research Report–Forecast Till 2027” Report To Their Unique Collection.
 
The Global Thumb Arthritis Market is expected to grow at an approximate CAGR of 8.1% during the forecast period.

Thumb or carpometacarpal (CMC) joint arthritis is a common type of arthritis affecting the hands. In the patients with thumb arthritis, the cushion-like cartilage inside the CMC joint breaks down, causing the bones to rub against each other. Some of the common symptoms of the disease are inclusive of thumb joint pain, thumb base swelling, besides others. The prevalence of the thumb arthritis is increasing which is the major driver for the market growth. In 2016, according to a study published in the HAND (American Association for Hand Surgery) journal, the prevalence of the thumb CMC osteoarthritis was estimated to be around 8% to 12% in the general population. Moreover, growing geriatric and obese population along with the rising healthcare expenditure is estimated to boost the market growth during the forecast period. According to the World Health Organization in 2016, approximately more than 1.9 billion adults, were estimated to be overweight, accounting for 650 million obese people. Additionally, according to the World Health Organization, the world’s geriatric population is estimated to reach 2 billion by 2050 from 900 million in 2015. However, the high cost of the surgical therapeutics along with related complications is estimated to restrain the market growth during the forecast period. According to a study published in the Plastic and Reconstructive Surgery journal in 2016, the cost of therapeutic trapeziectomy with LRTI for a majority of the patients (89%) was estimated to be about around USD 2,576.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5238

Segmentation

The global thumb arthritis market is segmented on the basis of type, diagnosis, treatment, and end user.

On the basis of the type, the market is segmented into osteoarthritis thumb arthritis, rheumatoid thumb arthritis, and others.

On the basis of the diagnosis, the market is segmented into physical examinations, imaging, fine needle aspiration (FNA), and others. The imaging segment is sub-segmented into X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and others.

On the basis of the treatment, the market is segmented into thumb exercise, medication, surgery, and others. The medication segment is sub-segmented into OCT medications, prescription medications, and others. The OCT medications, by treatment, is further segmented into acetaminophen, ibuprofen, and others. The prescription medications sub-segment, by treatment, is further segmented into celecoxib, meloxicam, and others. The surgery segment is sub-segmented into trapeziectomy, osteotomy, and others.

On the basis of the end users, the market is segmented into hospitals & clinics, research organizations, retail pharmacies, and others.

Key players in global thumb arthritis market

The key players in the global thumb arthritis market are inclusive of BioPro (U.S.), McKie Splints (U.S.), AbbVie Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Amgen Inc. (U.S.), Pfizer Inc. (U.S.), Carestream Health. (U.S.), General Electric Company (U.K), and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/thumb-arthritis-market-5238
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Depp
Phone 16468459312
Business Address Contact Us:
Market Research Future
Country India
Categories Health , Medical , News
Tags thumb arthritis market
Last Updated June 21, 2021